-transparent.png){kind=logo}
Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension. 2017
Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona College of Medicine, Tucson, AZ, USA.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
February 2003,
Current hypertension reports,
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
March 2007,
Clinics in chest medicine,
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
June 1993,
Journal of hypertension,
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
December 1993,
The New England journal of medicine,
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
January 1993,
Current opinion in nephrology and hypertension,
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
January 2000,
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
June 2012,
Circulation,
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
June 2004,
Journal of the American College of Cardiology,
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
January 2001,
Circulation research,
Haiyang Tang, and
Rebecca R Vanderpool, and
Jian Wang, and
Jason X-J Yuan
November 2021,
Journal of cardiovascular pharmacology and therapeutics,
